<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35812435</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>12</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Extracellular Vesicles Derived From <i>Ex Vivo</i> Expanded Regulatory T Cells Modulate <i>In Vitro</i> and <i>In Vivo</i> Inflammation.</ArticleTitle><Pagination><StartPage>875825</StartPage><MedlinePgn>875825</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">875825</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2022.875825</ELocationID><Abstract><AbstractText>Extracellular vehicles (EVs) are efficient biomarkers of disease and participate in disease pathogenesis; however, their use as clinical therapies to modify disease outcomes remains to be determined. Cell-based immune therapies, including regulatory T cells (Tregs), are currently being clinically evaluated for their usefulness in suppressing pro-inflammatory processes. The present study demonstrates that <i>ex vivo</i> expanded Tregs generate a large pool of EVs that express Treg-associated markers and suppress pro-inflammatory responses <i>in vitro</i> and <i>in vivo</i>. Intravenous injection of Treg EVs into an LPS-induced mouse model of inflammation reduced peripheral pro-inflammatory transcripts and increased anti-inflammatory transcripts in myeloid cells as well as Tregs. Intranasal administration of enriched Treg EVs in this model also reduced pro-inflammatory transcripts and the associated neuroinflammatory responses. In a mouse model of amyotrophic lateral sclerosis, intranasal administration of enriched Treg EVs slowed disease progression, increased survival, and modulated inflammation within the diseased spinal cord. These findings support the therapeutic potential of expanded Treg EVs to suppress pro-inflammatory responses in human disease.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Thome, Thonhoff, Zhao, Faridar, Wang, Beers and Appel.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Thome</LastName><ForeName>Aaron D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Department of Neurology, Houston Methodist Neurological Institute, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thonhoff</LastName><ForeName>Jason R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of Neurology, Houston Methodist Neurological Institute, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Weihua</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neurology, Houston Methodist Neurological Institute, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faridar</LastName><ForeName>Alireza</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Houston Methodist Neurological Institute, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jinghong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Houston Methodist Neurological Institute, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beers</LastName><ForeName>David R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Department of Neurology, Houston Methodist Neurological Institute, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Appel</LastName><ForeName>Stanley H</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Neurology, Houston Methodist Neurological Institute, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000067128" MajorTopicYN="Y">Extracellular Vesicles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050378" MajorTopicYN="N">T-Lymphocytes, Regulatory</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">exosome (vesicle)</Keyword><Keyword MajorTopicYN="N">immune modulation</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">inflammatory disease</Keyword><Keyword MajorTopicYN="N">neurodegenerative disease</Keyword><Keyword MajorTopicYN="N">neuroinflammation</Keyword><Keyword MajorTopicYN="N">peripheral inflammation</Keyword></KeywordList><CoiStatement>AT reports consulting work with respect to Coya Therapeutics. SA is the chair of the scientific advisory board for Coya Therapeutics. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>11</Day><Hour>3</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35812435</ArticleId><ArticleId IdType="pmc">PMC9258040</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2022.875825</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>H Rashed M, Bayraktar EK, Helal G, Abd-Ellah MF, Amero P, Chavez-Reyes A, et al. . Exosomes: From Garbage Bins to Promising Therapeutic Targets. Int J Mol Sci (2017) 18(3):538. doi: 10.3390/ijms18030538</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18030538</ArticleId><ArticleId IdType="pmc">PMC5372554</ArticleId><ArticleId IdType="pubmed">28257101</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagarajah S. Exosome Secretion - More Than Simple Waste Disposal? Implications for Physiology, Diagnostics and Therapeutics. J Circ Biomark (2016) 5:7. doi: 10.5772/62975</Citation><ArticleIdList><ArticleId IdType="doi">10.5772/62975</ArticleId><ArticleId IdType="pmc">PMC5548323</ArticleId><ArticleId IdType="pubmed">28936255</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurung S, Perocheau D, Touramanidou L, Baruteau J. The Exosome Journey: From Biogenesis to Uptake and Intracellular Signalling. Cell Commun Signal (2021) 19(1):47. doi: 10.1186/s12964-021-00730-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12964-021-00730-1</ArticleId><ArticleId IdType="pmc">PMC8063428</ArticleId><ArticleId IdType="pubmed">33892745</ArticleId></ArticleIdList></Reference><Reference><Citation>Meldolesi J. Exosomes and Ectosomes in Intercellular Communication. Curr Biol (2018) 28(8):R435&#x2013;R44. doi: 10.1016/j.cub.2018.01.059</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2018.01.059</ArticleId><ArticleId IdType="pubmed">29689228</ArticleId></ArticleIdList></Reference><Reference><Citation>Isola AL, Chen S. Exosomes: The Messengers of Health and Disease. Curr Neuropharmacol (2017) 15(1):157&#x2013;65. doi:&#xa0;10.2174/1570159x14666160825160421</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1570159x14666160825160421</ArticleId><ArticleId IdType="pmc">PMC5327461</ArticleId><ArticleId IdType="pubmed">27568544</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohno S, Ishikawa A, Kuroda M. Roles of Exosomes and Microvesicles in Disease Pathogenesis. Adv Drug Deliv Rev (2013) 65(3):398&#x2013;401. doi: 10.1016/j.addr.2012.07.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.addr.2012.07.019</ArticleId><ArticleId IdType="pubmed">22981801</ArticleId></ArticleIdList></Reference><Reference><Citation>Samanta S, Rajasingh S, Drosos N, Zhou Z, Dawn B, Rajasingh J. Exosomes: New Molecular Targets of Diseases. Acta Pharmacol Sin (2018) 39(4):501&#x2013;13. doi: 10.1038/aps.2017.162</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/aps.2017.162</ArticleId><ArticleId IdType="pmc">PMC5888687</ArticleId><ArticleId IdType="pubmed">29219950</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Liu Y, Liu H, Tang WH. Exosomes: Biogenesis, Biologic Function and Clinical Potential. Cell Biosci (2019) 9:19. doi: 10.1186/s13578-019-0282-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13578-019-0282-2</ArticleId><ArticleId IdType="pmc">PMC6377728</ArticleId><ArticleId IdType="pubmed">30815248</ArticleId></ArticleIdList></Reference><Reference><Citation>Doyle LM, Wang MZ. Overview of Extracellular Vesicles, Their Origin, Composition, Purpose, and Methods for Exosome Isolation and Analysis. Cells (2019) 8(7):727. doi: 10.3390/cells8070727</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8070727</ArticleId><ArticleId IdType="pmc">PMC6678302</ArticleId><ArticleId IdType="pubmed">31311206</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalluri R, LeBleu VS. The Biology, Function, and Biomedical Applications of Exosomes. Science (2020) 367(6478):eaau6977. doi: 10.1126/science.aau6977</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aau6977</ArticleId><ArticleId IdType="pmc">PMC7717626</ArticleId><ArticleId IdType="pubmed">32029601</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratajczak MZ, Ratajczak J. Extracellular Microvesicles/Exosomes: Discovery, Disbelief, Acceptance, and the Future? Leukemia (2020) 34(12):3126&#x2013;35. doi: 10.1038/s41375-020-01041-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41375-020-01041-z</ArticleId><ArticleId IdType="pmc">PMC7685969</ArticleId><ArticleId IdType="pubmed">32929129</ArticleId></ArticleIdList></Reference><Reference><Citation>ELA S, Mager I, Breakefield XO, Wood MJ. Extracellular Vesicles: Biology and Emerging Therapeutic Opportunities. Nat Rev Drug Discov (2013) 12(5):347&#x2013;57. doi:&#xa0;10.1038/nrd3978</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd3978</ArticleId><ArticleId IdType="pubmed">23584393</ArticleId></ArticleIdList></Reference><Reference><Citation>Stahl PD, Raposo G. Extracellular Vesicles: Exosomes and Microvesicles, Integrators of Homeostasis. Physiol (Bethesda) (2019) 34(3):169&#x2013;77. doi: 10.1152/physiol.00045.2018</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physiol.00045.2018</ArticleId><ArticleId IdType="pubmed">30968753</ArticleId></ArticleIdList></Reference><Reference><Citation>Camussi G, Deregibus MC, Bruno S, Cantaluppi V, Biancone L. Exosomes/Microvesicles as a Mechanism of Cell-to-Cell Communication. Kidney Int (2010) 78(9):838&#x2013;48. doi: 10.1038/ki.2010.278</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2010.278</ArticleId><ArticleId IdType="pubmed">20703216</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai CP, Breakefield XO. Role of Exosomes/Microvesicles in the Nervous System and Use in Emerging Therapies. Front Physiol (2012) 3:228. doi: 10.3389/fphys.2012.00228</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2012.00228</ArticleId><ArticleId IdType="pmc">PMC3384085</ArticleId><ArticleId IdType="pubmed">22754538</ArticleId></ArticleIdList></Reference><Reference><Citation>Stahl AL, Johansson K, Mossberg M, Kahn R, Karpman D. Exosomes and Microvesicles in Normal Physiology, Pathophysiology, and Renal Diseases. Pediatr Nephrol (2019) 34(1):11&#x2013;30. doi: 10.1007/s00467-017-3816-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00467-017-3816-z</ArticleId><ArticleId IdType="pmc">PMC6244861</ArticleId><ArticleId IdType="pubmed">29181712</ArticleId></ArticleIdList></Reference><Reference><Citation>van Niel G, D'Angelo G, Raposo G. Shedding Light on the Cell Biology of Extracellular Vesicles. Nat Rev Mol Cell Biol (2018) 19(4):213&#x2013;28. doi: 10.1038/nrm.2017.125</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm.2017.125</ArticleId><ArticleId IdType="pubmed">29339798</ArticleId></ArticleIdList></Reference><Reference><Citation>McKelvey KJ, Powell KL, Ashton AW, Morris JM, McCracken SA. Exosomes: Mechanisms of Uptake. J Circ biomark (2015) 4:7. doi: 10.5772/61186</Citation><ArticleIdList><ArticleId IdType="doi">10.5772/61186</ArticleId><ArticleId IdType="pmc">PMC5572985</ArticleId><ArticleId IdType="pubmed">28936243</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulcahy LA, Pink RC, Carter DR. Routes and Mechanisms of Extracellular Vesicle Uptake. J Extracell Vesicles (2014) 3. doi: 10.3402/jev.v3.24641</Citation><ArticleIdList><ArticleId IdType="doi">10.3402/jev.v3.24641</ArticleId><ArticleId IdType="pmc">PMC4122821</ArticleId><ArticleId IdType="pubmed">25143819</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W, Bai X, Zhang A, Huang J, Xu S, Zhang J. Role of Exosomes in Central Nervous System Diseases. Front Mol Neurosci (2019) 12:240. doi: 10.3389/fnmol.2019.00240</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00240</ArticleId><ArticleId IdType="pmc">PMC6787718</ArticleId><ArticleId IdType="pubmed">31636538</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeedi S, Israel S, Nagy C, Turecki G. The Emerging Role of Exosomes in Mental Disorders. Transl Psychiatry (2019) 9(1):122. doi: 10.1038/s41398-019-0459-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-019-0459-9</ArticleId><ArticleId IdType="pmc">PMC6438960</ArticleId><ArticleId IdType="pubmed">30923321</ArticleId></ArticleIdList></Reference><Reference><Citation>Othman N, Jamal R, Abu N. Cancer-Derived Exosomes as Effectors of Key Inflammation-Related Players. Front Immunol (2019) 10:2103. doi: 10.3389/fimmu.2019.02103</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02103</ArticleId><ArticleId IdType="pmc">PMC6737008</ArticleId><ArticleId IdType="pubmed">31555295</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A, Pulliam L. Exosomes as Mediators of Neuroinflammation. J&#xa0;Neuroinflamm (2014) 11:68. doi: 10.1186/1742-2094-11-68</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-11-68</ArticleId><ArticleId IdType="pmc">PMC3994210</ArticleId><ArticleId IdType="pubmed">24694258</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim YJ, Lee SJ. Are Exosomes the Vehicle for Protein Aggregate Propagation in Neurodegenerative Diseases? Acta Neuropathol Commun (2017) 5(1):64. doi: 10.1186/s40478-017-0467-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-017-0467-z</ArticleId><ArticleId IdType="pmc">PMC5576311</ArticleId><ArticleId IdType="pubmed">28851422</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruan Z, Pathak D, Venkatesan Kalavai S, Yoshii-Kitahara A, Muraoka S, Bhatt N, et al. . Alzheimer's Disease Brain-Derived Extracellular Vesicles Spread Tau Pathology in Interneurons. Brain (2021) 144(1):288&#x2013;309. doi: 10.1093/brain/awaa376</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa376</ArticleId><ArticleId IdType="pmc">PMC7880668</ArticleId><ArticleId IdType="pubmed">33246331</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, Jiang X, Bao J, Wang Y, Liu H, Tang L. Exosomes in Pathogen Infections: A Bridge to Deliver Molecules and Link Functions. Front Immunol (2018) 9:90. doi: 10.3389/fimmu.2018.00090</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00090</ArticleId><ArticleId IdType="pmc">PMC5816030</ArticleId><ArticleId IdType="pubmed">29483904</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian X, An N, Ren Y, Yang C, Zhang X, Li L. Immunosuppressive Effects of Mesenchymal Stem Cells-Derived Exosomes. Stem Cell Rev Rep (2021) 17(2):411&#x2013;27. doi: 10.1007/s12015-020-10040-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12015-020-10040-7</ArticleId><ArticleId IdType="pubmed">32935222</ArticleId></ArticleIdList></Reference><Reference><Citation>Robbins PD, Dorronsoro A, Booker CN. Regulation of Chronic Inflammatory and Immune Processes by Extracellular Vesicles. J Clin Invest (2016) 126(4):1173&#x2013;80. doi: 10.1172/JCI81131</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI81131</ArticleId><ArticleId IdType="pmc">PMC4811148</ArticleId><ArticleId IdType="pubmed">27035808</ArticleId></ArticleIdList></Reference><Reference><Citation>Suh JH, Joo HS, Hong EB, Lee HJ, Lee JM. Therapeutic Application of Exosomes in Inflammatory Diseases. Int J Mol Sci (2021) 22(3):1144. doi: 10.3390/ijms22031144</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22031144</ArticleId><ArticleId IdType="pmc">PMC7865921</ArticleId><ArticleId IdType="pubmed">33498928</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang TT, Wang B, Lv LL, Liu BC. Extracellular Vesicle-Based Nanotherapeutics: Emerging Frontiers in Anti-Inflammatory Therapy. Theranostics (2020) 10(18):8111&#x2013;29. doi: 10.7150/thno.47865</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.47865</ArticleId><ArticleId IdType="pmc">PMC7381724</ArticleId><ArticleId IdType="pubmed">32724461</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C, Robbins PD. Immunosuppressive Exosomes: A New Approach for Treating Arthritis. Int J Rheumatol (2012) 2012:573528. doi: 10.1155/2012/573528</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/573528</ArticleId><ArticleId IdType="pmc">PMC3324137</ArticleId><ArticleId IdType="pubmed">22548070</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee BC, Kang I, Yu KR. Therapeutic Features and Updated Clinical Trials of Mesenchymal Stem Cell (MSC)-Derived Exosomes. J Clin Med (2021) 10(4):711. doi: 10.3390/jcm10040711</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10040711</ArticleId><ArticleId IdType="pmc">PMC7916919</ArticleId><ArticleId IdType="pubmed">33670202</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikfarjam S, Rezaie J, Zolbanin NM, Jafari R. Mesenchymal Stem Cell Derived-Exosomes: A Modern Approach in Translational Medicine. J Transl Med (2020) 18(1):449. doi: 10.1186/s12967-020-02622-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02622-3</ArticleId><ArticleId IdType="pmc">PMC7691969</ArticleId><ArticleId IdType="pubmed">33246476</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers DR, Zhao W, Appel SH. The Role of Regulatory T Lymphocytes in Amyotrophic Lateral Sclerosis. JAMA Neurol (2018) 75(6):656&#x2013;8. doi: 10.1001/jamaneurol.2018.0043</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2018.0043</ArticleId><ArticleId IdType="pubmed">29507936</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers DR, Zhao W, Wang J, Zhang X, Wen S, Neal D, et al. . ALS Patients' Regulatory T Lymphocytes Are Dysfunctional, and Correlate With Disease Progression Rate and Severity. JCI Insight (2017) 2(5):e89530. doi: 10.1172/jci.insight.89530</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.89530</ArticleId><ArticleId IdType="pmc">PMC5333967</ArticleId><ArticleId IdType="pubmed">28289705</ArticleId></ArticleIdList></Reference><Reference><Citation>Faridar A, Thome AD, Zhao W, Thonhoff JR, Beers DR, Pascual B, et al. . Restoring Regulatory T-Cell Dysfunction in Alzheimer's Disease Through Ex Vivo Expansion. Brain Commun (2020) 2(2):fcaa112. doi: 10.1093/braincomms/fcaa112</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa112</ArticleId><ArticleId IdType="pmc">PMC7472911</ArticleId><ArticleId IdType="pubmed">32954348</ArticleId></ArticleIdList></Reference><Reference><Citation>He F, Balling R. The Role of Regulatory T Cells in Neurodegenerative Diseases. Wiley Interdiscip Rev Syst Biol Med (2013) 5(2):153&#x2013;80. doi: 10.1002/wsbm.1187</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wsbm.1187</ArticleId><ArticleId IdType="pubmed">22899644</ArticleId></ArticleIdList></Reference><Reference><Citation>Thome AD, Atassi F, Wang J, Faridar A, Zhao W, Thonhoff JR, et al. . Ex Vivo Expansion of Dysfunctional Regulatory T Lymphocytes Restores Suppressive Function in Parkinson's Disease. NPJ Parkinsons Dis (2021) 7(1):41. doi: 10.1038/s41531-021-00188-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41531-021-00188-5</ArticleId><ArticleId IdType="pmc">PMC8119976</ArticleId><ArticleId IdType="pubmed">33986285</ArticleId></ArticleIdList></Reference><Reference><Citation>Thome AD, Faridar A, Beers DR, Thonhoff JR, Zhao W, Wen S, et al. . Functional Alterations of Myeloid Cells During the Course of Alzheimer's Disease. Mol Neurodegener (2018) 13(1):61. doi: 10.1186/s13024-018-0293-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-018-0293-1</ArticleId><ArticleId IdType="pmc">PMC6233576</ArticleId><ArticleId IdType="pubmed">30424785</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W, Beers DR, Hooten KG, Sieglaff DH, Zhang A, Kalyana-Sundaram S, et al. . Characterization of Gene Expression Phenotype in Amyotrophic Lateral Sclerosis Monocytes. JAMA Neurol (2017) 74(6):677&#x2013;85. doi: 10.1001/jamaneurol.2017.0357</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2017.0357</ArticleId><ArticleId IdType="pmc">PMC5822209</ArticleId><ArticleId IdType="pubmed">28437540</ArticleId></ArticleIdList></Reference><Reference><Citation>Skaper SD, Facci L, Zusso M, Giusti P. An Inflammation-Centric View of Neurological Disease: Beyond the Neuron. Front Cell Neurosci (2018) 12:72. doi: 10.3389/fncel.2018.00072</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2018.00072</ArticleId><ArticleId IdType="pmc">PMC5871676</ArticleId><ArticleId IdType="pubmed">29618972</ArticleId></ArticleIdList></Reference><Reference><Citation>Machhi J, Kevadiya BD, Muhammad IK, Herskovitz J, Olson KE, Mosley RL, et al. . Harnessing Regulatory T Cell Neuroprotective Activities for Treatment of Neurodegenerative Disorders. Mol Neurodegener (2020) 15(1):32. doi: 10.1186/s13024-020-00375-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-020-00375-7</ArticleId><ArticleId IdType="pmc">PMC7275301</ArticleId><ArticleId IdType="pubmed">32503641</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu WY, Wang X, Ip NY. Targeting Neuroinflammation as a Therapeutic Strategy for Alzheimer's Disease: Mechanisms, Drug Candidates, and New Opportunities. ACS Chem Neurosci (2019) 10(2):872&#x2013;9. doi: 10.1021/acschemneuro.8b00402</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.8b00402</ArticleId><ArticleId IdType="pubmed">30221933</ArticleId></ArticleIdList></Reference><Reference><Citation>Olson KE, Gendelman HE. Immunomodulation as a Neuroprotective and Therapeutic Strategy for Parkinson's Disease. Curr Opin Pharmacol (2016) 26:87&#x2013;95. doi: 10.1016/j.coph.2015.10.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coph.2015.10.006</ArticleId><ArticleId IdType="pmc">PMC4716884</ArticleId><ArticleId IdType="pubmed">26571205</ArticleId></ArticleIdList></Reference><Reference><Citation>Thonhoff JR, Simpson EP, Appel SH. Neuroinflammatory Mechanisms in Amyotrophic Lateral Sclerosis Pathogenesis. Curr Opin Neurol (2018) 31(5):635&#x2013;9. doi: 10.1097/WCO.0000000000000599</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000599</ArticleId><ArticleId IdType="pubmed">30048339</ArticleId></ArticleIdList></Reference><Reference><Citation>Alsuliman A, Appel SH, Beers DR, Basar R, Shaim H, Kaur I, et al. . A Robust, Good Manufacturing Practice-Compliant, Clinical-Scale Procedure to Generate Regulatory T Cells From Patients With Amyotrophic Lateral Sclerosis for Adoptive Cell Therapy. Cytotherapy (2016) 18(10):1312&#x2013;24. doi: 10.1016/j.jcyt.2016.06.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcyt.2016.06.012</ArticleId><ArticleId IdType="pubmed">27497700</ArticleId></ArticleIdList></Reference><Reference><Citation>Thonhoff JR, Beers DR, Zhao W, Pleitez M, Simpson EP, Berry JD, et al. . Expanded Autologous Regulatory T-Lymphocyte Infusions in ALS: A Phase I, First-in-Human Study. Neurol Neuroimmunol Neuroinflamm (2018) 5(4):e465. doi: 10.1212/NXI.0000000000000465</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000465</ArticleId><ArticleId IdType="pmc">PMC5961523</ArticleId><ArticleId IdType="pubmed">29845093</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal A, Fanelli G, Letizia M, Tung SL, Boardman D, Lechler R, et al. . Regulatory T Cell-Derived Exosomes: Possible Therapeutic and Diagnostic Tools in Transplantation. Front Immunol (2014) 5:555. doi: 10.3389/fimmu.2014.00555</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2014.00555</ArticleId><ArticleId IdType="pmc">PMC4220709</ArticleId><ArticleId IdType="pubmed">25414702</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao Y, Pan X, Fu R. Role and Function of T Cell-Derived Exosomes and Their Therapeutic Value. Mediators Inflamm (2021) 2021:8481013. doi: 10.1155/2021/8481013</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/8481013</ArticleId><ArticleId IdType="pmc">PMC8604589</ArticleId><ArticleId IdType="pubmed">34803518</ArticleId></ArticleIdList></Reference><Reference><Citation>Busatto S, Vilanilam G, Ticer T, Lin WL, Dickson DW, Shapiro S, et al. . Tangential Flow Filtration for Highly Efficient Concentration of Extracellular Vesicles From Large Volumes of Fluid. Cells (2018) 7(12):273. doi: 10.3390/cells7120273</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells7120273</ArticleId><ArticleId IdType="pmc">PMC6315734</ArticleId><ArticleId IdType="pubmed">30558352</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W, Beers DR, Thonhoff JR, Thome AD, Faridar A, Wang J, et al. . Immunosuppressive Functions of M2 Macrophages Derived From iPSCs of Patients With ALS and Healthy Controls. iScience (2020) 23(6):101192. doi: 10.1016/j.isci.2020.101192</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2020.101192</ArticleId><ArticleId IdType="pmc">PMC7286967</ArticleId><ArticleId IdType="pubmed">32521508</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta D, Zickler AM, El Andaloussi S. Dosing Extracellular Vesicles. Adv Drug Deliv Rev (2021) 178:113961. doi: 10.1016/j.addr.2021.113961</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.addr.2021.113961</ArticleId><ArticleId IdType="pubmed">34481030</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, et al. . Motor Neuron Degeneration in Mice That Express a Human Cu,Zn Superoxide Dismutase Mutation. Science (1994) 264(5166):1772&#x2013;5. doi: 10.1126/science.8209258</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers DR, Henkel JS, Xiao Q, Zhao W, Wang J, Yen AA, et al. . Wild-Type Microglia Extend Survival in PU.1 Knockout Mice With Familial Amyotrophic Lateral Sclerosis. Proc Natl Acad Sci USA (2006) 103(43):16021&#x2013;6. doi:&#xa0;10.1073/pnas.0607423103</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0607423103</ArticleId><ArticleId IdType="pmc">PMC1613228</ArticleId><ArticleId IdType="pubmed">17043238</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers DR, Henkel JS, Zhao W, Wang J, Appel SH. CD4+ T Cells Support Glial Neuroprotection, Slow Disease Progression, and Modify Glial Morphology in an Animal Model of Inherited ALS. Proc Natl Acad Sci USA (2008) 105(40):15558&#x2013;63. doi: 10.1073/pnas.0807419105</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0807419105</ArticleId><ArticleId IdType="pmc">PMC2547419</ArticleId><ArticleId IdType="pubmed">18809917</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers DR, Zhao W, Liao B, Kano O, Wang J, Huang A, et al. . Neuroinflammation Modulates Distinct Regional and Temporal Clinical Responses in ALS Mice. Brain Behav Immun (2011) 25(5):1025&#x2013;35. doi: 10.1016/j.bbi.2010.12.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2010.12.008</ArticleId><ArticleId IdType="pmc">PMC3096756</ArticleId><ArticleId IdType="pubmed">21176785</ArticleId></ArticleIdList></Reference><Reference><Citation>Lotvall J, Hill AF, Hochberg F, Buzas EI, Di Vizio D, Gardiner C, et al. . Minimal Experimental Requirements for Definition of Extracellular Vesicles and Their Functions: A Position Statement From the International Society for Extracellular Vesicles. J Extracell Vesicles (2014) 3:26913. doi: 10.3402/jev.v3.26913</Citation><ArticleIdList><ArticleId IdType="doi">10.3402/jev.v3.26913</ArticleId><ArticleId IdType="pmc">PMC4275645</ArticleId><ArticleId IdType="pubmed">25536934</ArticleId></ArticleIdList></Reference><Reference><Citation>Thery C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, et al. . Minimal Information for Studies of Extracellular Vesicles 2018 (MISEV2018): A Position Statement of the International Society for Extracellular Vesicles and Update of the MISEV2014 Guidelines. J Extracell Vesicles (2018) 7(1):1535750. doi: 10.1080/20013078.2018.1535750</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/20013078.2018.1535750</ArticleId><ArticleId IdType="pmc">PMC6322352</ArticleId><ArticleId IdType="pubmed">30637094</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu X, Leak RK, Thomson AW, Yu F, Xia Y, Wechsler LR, et al. . Promises and Limitations of Immune Cell-Based Therapies in Neurological Disorders. Nat Rev Neurol (2018) 14(9):559&#x2013;68. doi: 10.1038/s41582-018-0028-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0028-5</ArticleId><ArticleId IdType="pmc">PMC6237550</ArticleId><ArticleId IdType="pubmed">29925925</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Huang H, Zhang W, Ding F, Fan Z, Zeng Z. Exosomes Derived From T Regulatory Cells Suppress CD8+ Cytotoxic T Lymphocyte Proliferation and Prolong Liver Allograft Survival. Med Sci Monit (2019) 25:4877&#x2013;84. doi: 10.12659/MSM.917058</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.917058</ArticleId><ArticleId IdType="pmc">PMC6618337</ArticleId><ArticleId IdType="pubmed">31258152</ArticleId></ArticleIdList></Reference><Reference><Citation>Okoye IS, Coomes SM, Pelly VS, Czieso S, Papayannopoulos V, Tolmachova T, et al. . MicroRNA-Containing T-Regulatory-Cell-Derived Exosomes Suppress Pathogenic T Helper 1 Cells. Immunity (2014) 41(3):503. doi:&#xa0;10.1016/j.immuni.2014.08.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2014.08.008</ArticleId><ArticleId IdType="pmc">PMC5640441</ArticleId><ArticleId IdType="pubmed">28903020</ArticleId></ArticleIdList></Reference><Reference><Citation>Smyth LA, Ratnasothy K, Tsang JY, Boardman D, Warley A, Lechler R, et al. . CD73 Expression on Extracellular Vesicles Derived From CD4+ CD25+ Foxp3+ T Cells Contributes to Their Regulatory Function. Eur J Immunol (2013) 43(9):2430&#x2013;40. doi: 10.1002/eji.201242909</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201242909</ArticleId><ArticleId IdType="pubmed">23749427</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung SL, Boardman DA, Sen M, Letizia M, Peng Q, Cianci N, et al. . Regulatory T Cell-Derived Extracellular Vesicles Modify Dendritic Cell Function. Sci Rep (2018) 8(1):6065. doi: 10.1038/s41598-018-24531-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-24531-8</ArticleId><ArticleId IdType="pmc">PMC5904112</ArticleId><ArticleId IdType="pubmed">29666503</ArticleId></ArticleIdList></Reference><Reference><Citation>Bollyky PL, Falk BA, Long SA, Preisinger A, Braun KR, Wu RP, et al. . CD44 Costimulation Promotes FoxP3+ Regulatory T Cell Persistence and Function via Production of IL-2, IL-10, and TGF-Beta. J Immunol (2009) 183(4):2232&#x2013;41. doi: 10.4049/jimmunol.0900191</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0900191</ArticleId><ArticleId IdType="pmc">PMC3057032</ArticleId><ArticleId IdType="pubmed">19635906</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T, Soong L, Liu G, Konig R, Chopra AK. CD44 Expression Positively Correlates With Foxp3 Expression and Suppressive Function of CD4+ Treg Cells. Biol Direct (2009) 4:40. doi: 10.1186/1745-6150-4-40</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1745-6150-4-40</ArticleId><ArticleId IdType="pmc">PMC2770033</ArticleId><ArticleId IdType="pubmed">19852824</ArticleId></ArticleIdList></Reference><Reference><Citation>Battaglia M, Roncarolo MG. The Fate of Human Treg Cells. Immunity (2009) 30(6):763&#x2013;5. doi: 10.1016/j.immuni.2009.06.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2009.06.006</ArticleId><ArticleId IdType="pubmed">19538927</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyara M, Yoshioka Y, Kitoh A, Shima T, Wing K, Niwa A, et al. . Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor. Immunity (2009) 30(6):899&#x2013;911. doi: 10.1016/j.immuni.2009.03.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2009.03.019</ArticleId><ArticleId IdType="pubmed">19464196</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaier M, Seissler N, Becker LE, Schaefer SM, Schmitt E, Meuer S, et al. . The Extent of HLA-DR Expression on HLA-DR(+) Tregs Allows the Identification of Patients With Clinically Relevant Borderline Rejection. Transpl Int (2013) 26(3):290&#x2013;9. doi: 10.1111/tri.12032</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tri.12032</ArticleId><ArticleId IdType="pubmed">23279010</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakaguchi S, Mikami N, Wing JB, Tanaka A, Ichiyama K, Ohkura N. Regulatory T Cells and Human Disease. Annu Rev Immunol (2020) 38:541&#x2013;66. doi: 10.1146/annurev-immunol-042718-041717</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-042718-041717</ArticleId><ArticleId IdType="pubmed">32017635</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T Cells and Immune Tolerance. Cell (2008) 133(5):775&#x2013;87. doi: 10.1016/j.cell.2008.05.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2008.05.009</ArticleId><ArticleId IdType="pubmed">18510923</ArticleId></ArticleIdList></Reference><Reference><Citation>Shevyrev D, Tereshchenko V. Treg Heterogeneity, Function, and Homeostasis. Front Immunol (2019) 10:3100. doi: 10.3389/fimmu.2019.03100</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.03100</ArticleId><ArticleId IdType="pmc">PMC6971100</ArticleId><ArticleId IdType="pubmed">31993063</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahmini FR, Shahgaldi S. Therapeutic Potential of Mesenchymal Stem Cell-Derived Extracellular Vesicles as Novel Cell-Free Therapy for Treatment of Autoimmune Disorders. Exp Mol Pathol (2021) 118:104566. doi: 10.1016/j.yexmp.2020.104566</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexmp.2020.104566</ArticleId><ArticleId IdType="pubmed">33160961</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SH, Bianco NR, Shufesky WJ, Morelli AE, Robbins PD. Effective Treatment of Inflammatory Disease Models With Exosomes Derived From Dendritic Cells Genetically Modified to Express IL-4. J Immunol (2007) 179(4):2242&#x2013;9. doi: 10.4049/jimmunol.179.4.2242</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.179.4.2242</ArticleId><ArticleId IdType="pubmed">17675485</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee BR, Kim JH, Choi ES, Cho JH, Kim E. Effect of Young Exosomes Injected in Aged Mice. Int J Nanomed (2018) 13:5335&#x2013;45. doi: 10.2147/IJN.S170680</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJN.S170680</ArticleId><ArticleId IdType="pmc">PMC6141108</ArticleId><ArticleId IdType="pubmed">30254438</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma J, Hampton JM, Valiente GR, Wada T, Steigelman H, Young MC, et al. . Therapeutic Development of Mesenchymal Stem Cells or Their Extracellular Vesicles to Inhibit Autoimmune-Mediated Inflammatory Processes in Systemic Lupus Erythematosus. Front Immunol (2017) 8:526. doi: 10.3389/fimmu.2017.00526</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.00526</ArticleId><ArticleId IdType="pmc">PMC5423896</ArticleId><ArticleId IdType="pubmed">28539924</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Liu Y, Li J, Wang T, Hei Y, Li H, et al. . Tail-Vein Injection of MSC-Derived Small Extracellular Vesicles Facilitates the Restoration of Hippocampal Neuronal Morphology and Function in APP / PS1 Mice. Cell Death Discov (2021) 7(1):230. doi: 10.1038/s41420-021-00620-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41420-021-00620-y</ArticleId><ArticleId IdType="pmc">PMC8418600</ArticleId><ArticleId IdType="pubmed">34482379</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, Wang L, Ruan L, Oh J, Dong X, Zhuge Q, et al. . Extracellular Vesicles Extracted From Young Donor Serum Attenuate Inflammaging via Partially Rejuvenating Aged T-Cell Immunotolerance. FASEB J (2018) 32(11):fj201800059R. doi: 10.1096/fj.201800059R</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201800059R</ArticleId><ArticleId IdType="pmc">PMC6181631</ArticleId><ArticleId IdType="pubmed">29782203</ArticleId></ArticleIdList></Reference><Reference><Citation>Dabrowska S, Andrzejewska A, Lukomska B, Janowski M. Neuroinflammation as a Target for Treatment of Stroke Using Mesenchymal Stem Cells and Extracellular Vesicles. J Neuroinflamm (2019) 16(1):178. doi: 10.1186/s12974-019-1571-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-019-1571-8</ArticleId><ArticleId IdType="pmc">PMC6743114</ArticleId><ArticleId IdType="pubmed">31514749</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding M, Shen Y, Wang P, Xie Z, Xu S, Zhu Z, et al. . Exosomes Isolated From Human Umbilical Cord Mesenchymal Stem Cells Alleviate Neuroinflammation and Reduce Amyloid-Beta Deposition by Modulating Microglial Activation in Alzheimer's Disease. Neurochem Res (2018) 43(11):2165&#x2013;77. doi: 10.1007/s11064-018-2641-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-018-2641-5</ArticleId><ArticleId IdType="pubmed">30259257</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalani A, Tyagi A, Tyagi N. Exosomes: Mediators of Neurodegeneration, Neuroprotection and Therapeutics. Mol Neurobiol (2014) 49(1):590&#x2013;600. doi: 10.1007/s12035-013-8544-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-013-8544-1</ArticleId><ArticleId IdType="pmc">PMC3951279</ArticleId><ArticleId IdType="pubmed">23999871</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni H, Yang S, Siaw-Debrah F, Hu J, Wu K, He Z, et al. . Exosomes Derived From Bone Mesenchymal Stem Cells Ameliorate Early Inflammatory Responses Following Traumatic Brain Injury. Front Neurosci (2019) 13:14. doi: 10.3389/fnins.2019.00014</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00014</ArticleId><ArticleId IdType="pmc">PMC6354067</ArticleId><ArticleId IdType="pubmed">30733666</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Ye Y, Su X, He J, Bai W, He X. MSCs-Derived Exosomes and Neuroinflammation, Neurogenesis and Therapy of Traumatic Brain Injury. Front Cell Neurosci (2017) 11:55. doi: 10.3389/fncel.2017.00055</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2017.00055</ArticleId><ArticleId IdType="pmc">PMC5329010</ArticleId><ArticleId IdType="pubmed">28293177</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson LR, Fine JM, Svitak AL, Faltesek KA. Intranasal Administration of CNS Therapeutics to Awake Mice. J Vis Exp (2013) (74):4440. doi: 10.3791/4440</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/4440</ArticleId><ArticleId IdType="pmc">PMC3653240</ArticleId><ArticleId IdType="pubmed">23608783</ArticleId></ArticleIdList></Reference><Reference><Citation>Long Q, Upadhya D, Hattiangady B, Kim DK, An SY, Shuai B, et al. . Intranasal MSC-Derived A1-Exosomes Ease Inflammation, and Prevent Abnormal Neurogenesis and Memory Dysfunction After Status Epilepticus. Proc Natl Acad Sci USA (2017) 114(17):E3536&#x2013;E45. doi: 10.1073/pnas.1703920114</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1703920114</ArticleId><ArticleId IdType="pmc">PMC5410779</ArticleId><ArticleId IdType="pubmed">28396435</ArticleId></ArticleIdList></Reference><Reference><Citation>Perets N, Hertz S, London M, Offen D. Intranasal Administration of Exosomes Derived From Mesenchymal Stem Cells Ameliorates Autistic-Like Behaviors of BTBR Mice. Mol Autism (2018) 9:57. doi: 10.1186/s13229-018-0240-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13229-018-0240-6</ArticleId><ArticleId IdType="pmc">PMC6249852</ArticleId><ArticleId IdType="pubmed">30479733</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren J, Liu Y, Yao Y, Feng L, Zhao X, Li Z, et al. . Intranasal Delivery of MSC-Derived Exosomes Attenuates Allergic Asthma via Expanding IL-10 Producing Lung Interstitial Macrophages in Mice. Int Immunopharmacol (2021) 91:107288. doi: 10.1016/j.intimp.2020.107288</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2020.107288</ArticleId><ArticleId IdType="pubmed">33360827</ArticleId></ArticleIdList></Reference><Reference><Citation>Xian P, Hei Y, Wang R, Wang T, Yang J, Li J, et al. . Mesenchymal Stem Cell-Derived Exosomes as a Nanotherapeutic Agent for Amelioration of Inflammation-Induced Astrocyte Alterations in Mice. Theranostics (2019) 9(20):5956&#x2013;75. doi: 10.7150/thno.33872</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.33872</ArticleId><ArticleId IdType="pmc">PMC6735367</ArticleId><ArticleId IdType="pubmed">31534531</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhdanova DY, Poltavtseva RA, Svirshchevskaya EV, Bobkova NV. Effect of Intranasal Administration of Multipotent Mesenchymal Stromal Cell Exosomes on Memory of Mice in Alzheimer's Disease Model. Bull Exp Biol Med (2021) 170(4):575&#x2013;82. doi: 10.1007/s10517-021-05109-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10517-021-05109-3</ArticleId><ArticleId IdType="pubmed">33725248</ArticleId></ArticleIdList></Reference><Reference><Citation>Betzer O, Perets N, Angel A, Motiei M, Sadan T, Yadid G, et al. . In Vivo Neuroimaging of Exosomes Using Gold Nanoparticles. ACS Nano (2017) 11(11):10883&#x2013;93. doi: 10.1021/acsnano.7b04495</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsnano.7b04495</ArticleId><ArticleId IdType="pubmed">28960957</ArticleId></ArticleIdList></Reference><Reference><Citation>Perets N, Betzer O, Shapira R, Brenstein S, Angel A, Sadan T, et al. . Golden Exosomes Selectively Target Brain Pathologies in Neurodegenerative and Neurodevelopmental Disorders. Nano Lett (2019) 19(6):3422&#x2013;31. doi: 10.1021/acs.nanolett.8b04148</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.nanolett.8b04148</ArticleId><ArticleId IdType="pubmed">30761901</ArticleId></ArticleIdList></Reference><Reference><Citation>Gowen A, Shahjin F, Chand S, Odegaard KE, Yelamanchili SV. Mesenchymal Stem Cell-Derived Extracellular Vesicles: Challenges in Clinical Applications. Front Cell Dev Biol (2020) 8:149. doi: 10.3389/fcell.2020.00149</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2020.00149</ArticleId><ArticleId IdType="pmc">PMC7080981</ArticleId><ArticleId IdType="pubmed">32226787</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrmann IK, Wood MJA, Fuhrmann G. Extracellular Vesicles as a Next-Generation Drug Delivery Platform. Nat Nanotechnol (2021) 16(7):748&#x2013;59. doi: 10.1038/s41565-021-00931-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41565-021-00931-2</ArticleId><ArticleId IdType="pubmed">34211166</ArticleId></ArticleIdList></Reference><Reference><Citation>Saleh AF, Lazaro-Ibanez E, Forsgard MA, Shatnyeva O, Osteikoetxea X, Karlsson F, et al. . Extracellular Vesicles Induce Minimal Hepatotoxicity and Immunogenicity. Nanoscale (2019) 11(14):6990&#x2013;7001. doi: 10.1039/C8NR08720B</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C8NR08720B</ArticleId><ArticleId IdType="pubmed">30916672</ArticleId></ArticleIdList></Reference><Reference><Citation>Villa F, Quarto R, Tasso R. Extracellular Vesicles as Natural, Safe and Efficient Drug Delivery Systems. Pharmaceutics (2019) 11(11):557. doi: 10.3390/pharmaceutics11110557</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pharmaceutics11110557</ArticleId><ArticleId IdType="pmc">PMC6920944</ArticleId><ArticleId IdType="pubmed">31661862</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu X, Badawi M, Pomeroy S, Sutaria DS, Xie Z, Baek A, et al. . Comprehensive Toxicity and Immunogenicity Studies Reveal Minimal Effects in Mice Following Sustained Dosing of Extracellular Vesicles Derived From HEK293T Cells. J Extracell Vesicles (2017) 6(1):1324730. doi: 10.1080/20013078.2017.1324730</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/20013078.2017.1324730</ArticleId><ArticleId IdType="pmc">PMC5505007</ArticleId><ArticleId IdType="pubmed">28717420</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei W, Ao Q, Wang X, Cao Y, Liu Y, Zheng SG, et al. . Mesenchymal Stem Cell-Derived Exosomes: A Promising Biological Tool in Nanomedicine. Front Pharmacol (2020) 11:590470. doi: 10.3389/fphar.2020.590470</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.590470</ArticleId><ArticleId IdType="pmc">PMC7944140</ArticleId><ArticleId IdType="pubmed">33716723</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng QL, Liu DW. Mesenchymal Stem Cell-Derived Exosomes: An Emerging Therapeutic Strategy for Normal and Chronic Wound Healing. World J Clin Cases (2021) 9(22):6218&#x2013;33. doi: 10.12998/wjcc.v9.i22.6218</Citation><ArticleIdList><ArticleId IdType="doi">10.12998/wjcc.v9.i22.6218</ArticleId><ArticleId IdType="pmc">PMC8362559</ArticleId><ArticleId IdType="pubmed">34434989</ArticleId></ArticleIdList></Reference><Reference><Citation>Dabrowska S, Andrzejewska A, Janowski M, Lukomska B. Immunomodulatory and Regenerative Effects of Mesenchymal Stem Cells and Extracellular Vesicles: Therapeutic Outlook for Inflammatory and Degenerative Diseases. Front Immunol (2020) 11:591065. doi: 10.3389/fimmu.2020.591065</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.591065</ArticleId><ArticleId IdType="pmc">PMC7893976</ArticleId><ArticleId IdType="pubmed">33613514</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabat M, Bobkov I, Kumar S, Grumet M. Trends in Mesenchymal Stem Cell Clinical Trials 2004-2018: Is Efficacy Optimal in a Narrow Dose Range? Stem Cells Transl Med (2020) 9(1):17&#x2013;27. doi: 10.1002/sctm.19-0202</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sctm.19-0202</ArticleId><ArticleId IdType="pmc">PMC6954709</ArticleId><ArticleId IdType="pubmed">31804767</ArticleId></ArticleIdList></Reference><Reference><Citation>Kodali M, Castro OW, Kim DK, Thomas A, Shuai B, Attaluri S, et al. . Intranasally Administered Human MSC-Derived Extracellular Vesicles Pervasively Incorporate Into Neurons and Microglia in Both Intact and Status Epilepticus Injured Forebrain. Int J Mol Sci (2019) 21(1):181. doi: 10.3390/ijms21010181</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21010181</ArticleId><ArticleId IdType="pmc">PMC6981466</ArticleId><ArticleId IdType="pubmed">31888012</ArticleId></ArticleIdList></Reference><Reference><Citation>Musial-Wysocka A, Kot M, Majka M. The Pros and Cons of Mesenchymal Stem Cell-Based Therapies. Cell Transplant (2019) 28(7):801&#x2013;12. doi: 10.1177/0963689719837897</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0963689719837897</ArticleId><ArticleId IdType="pmc">PMC6719501</ArticleId><ArticleId IdType="pubmed">31018669</ArticleId></ArticleIdList></Reference><Reference><Citation>Phinney DG, Pittenger MF. Concise Review: MSC-Derived Exosomes for Cell-Free Therapy. Stem Cells (2017) 35(4):851&#x2013;8. doi: 10.1002/stem.2575</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.2575</ArticleId><ArticleId IdType="pubmed">28294454</ArticleId></ArticleIdList></Reference><Reference><Citation>Squillaro T, Peluso G, Galderisi U. Clinical Trials With Mesenchymal Stem Cells: An Update. Cell Transplant (2016) 25(5):829&#x2013;48. doi: 10.3727/096368915X689622</Citation><ArticleIdList><ArticleId IdType="doi">10.3727/096368915X689622</ArticleId><ArticleId IdType="pubmed">26423725</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>